Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, Western Cape, South Africa.
PLoS One. 2013 Oct 14;8(10):e77532. doi: 10.1371/journal.pone.0077532. eCollection 2013.
Effusive constrictive pericarditis (ECP) is visceral constriction in conjunction with compressive pericardial effusion. The prevalence of proven tuberculous ECP is unknown. Whilst ECP is distinguished from effusive disease on hemodynamic grounds, it is unknown whether effusive-constrictive physiology has a distinct cytokine profile. We conducted a prospective study of prevalence and cytokine profile of effusive-constrictive disease in patients with tuberculous pericardial effusion.
From July 2006 through July 2009, the prevalence of ECP and serum and pericardial levels of inflammatory cytokines were determined in adults with tuberculous pericardial effusion. The diagnosis of ECP was made by combined pericardiocentesis and cardiac catheterization.
Of 91 patients evaluated, 68 had tuberculous pericarditis. The 36/68 patients (52.9%; 95% confidence interval [CI]: 41.2-65.4) with ECP were younger (29 versus 37 years, P=0.02), had a higher pre-pericardiocentesis right atrial pressure (17.0 versus 10.0 mmHg, P<0.0001), serum concentration of interleukin-10 (IL-10) (38.5 versus 0.2 pg/ml, P<0.001) and transforming growth factor-beta (121.5 versus 29.1 pg/ml, P=0.02), pericardial concentration of IL-10 (84.7 versus 20.4 pg/ml, P=0.006) and interferon-gamma (2,568.0 versus 906.6 pg/ml, P=0.03) than effusive non-constrictive cases. In multivariable regression analysis, right atrial pressure > 15 mmHg (odds ratio [OR] = 48, 95%CI: 8.7-265; P<0.0001) and IL-10 > 200 pg/ml (OR=10, 95%CI: 1.1, 93; P=0.04) were independently associated with ECP.
Effusive-constrictive disease occurs in half of cases of tuberculous pericardial effusion, and is characterized by greater elevation in the pre-pericardiocentesis right atrial pressure and pericardial and serum IL-10 levels compared to patients with effusive non-constrictive tuberculous pericarditis.
渗出性缩窄性心包炎(ECP)是内脏缩窄合并压迫性心包积液。已证实的结核性 ECP 的患病率尚不清楚。虽然 ECP 在血流动力学上与渗出性疾病不同,但尚不清楚渗出性缩窄性生理学是否具有独特的细胞因子谱。我们对结核性心包积液患者渗出性缩窄性疾病的患病率和细胞因子谱进行了前瞻性研究。
从 2006 年 7 月至 2009 年 7 月,对结核性心包积液患者的 ECP 患病率以及血清和心包液中炎症细胞因子水平进行了测定。通过联合心包穿刺和心导管术诊断 ECP。
在 91 例评估的患者中,68 例患有结核性心包炎。36/68 例(52.9%;95%置信区间[CI]:41.2-65.4)患者患有 ECP,他们更年轻(29 岁比 37 岁,P=0.02),心包穿刺前右心房压更高(17.0 毫米汞柱比 10.0 毫米汞柱,P<0.0001),血清白细胞介素-10(IL-10)浓度更高(38.5 比 0.2 皮克/毫升,P<0.001)和转化生长因子-β(TGF-β)(121.5 比 29.1 皮克/毫升,P=0.02),心包液中 IL-10(84.7 比 20.4 皮克/毫升,P=0.006)和干扰素-γ(IFN-γ)(2568.0 比 906.6 皮克/毫升,P=0.03)浓度更高。多变量回归分析显示,右心房压>15mmHg(比值比[OR] = 48,95%CI:8.7-265;P<0.0001)和 IL-10>200pg/ml(OR=10,95%CI:1.1,93;P=0.04)与 ECP 独立相关。
渗出性缩窄性疾病在结核性心包积液患者中占一半,与渗出性非缩窄性结核性心包炎患者相比,其心包穿刺前右心房压和心包液及血清 IL-10 水平升高更为明显。